Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by KR Kelly
Pnd99 - Cystic Fibrosis Therapies - Key Drivers Behind Differing Hta Decisions
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pnd100 - Pricing of Innovative Medicines: Do Innovative Schemes Offer a Solution?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Inhaled Therapies, Azithromycin andMycobacterium Abscessusin Cystic Fibrosis Patients
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Reproductive Decisions After Neonatal Screening Identifies Cystic Fibrosis
Archives of Disease in Childhood: Fetal and Neonatal Edition
Pediatrics
Gynecology
Perinatology
Obstetrics
Medicine
Child Health
Antiinflammatory Therapies for Cystic Fibrosis: Past, Present, and Future
Pharmacotherapy
Pharmacology
Php223 - Trerapeutic Areas, a Key Factor for Hta and Reimbursement Decisions, Timming and Access
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A G542X Cystic Fibrosis Mouse Model for Examining Nonsense Mutation Directed Therapies
PLoS ONE
Multidisciplinary
Cystic Fibrosis. 7. Management of Cystic Fibrosis in Different Countries. Cystic Fibrosis in Melbourne.
Thorax
Pulmonary
Respiratory Medicine
Cystic Fibrosis. 7. Management of Cystic Fibrosis in Different Countries. Cystic Fibrosis in Copenhagen.
Thorax
Pulmonary
Respiratory Medicine
Cystic Fibrosis.
Archives of Disease in Childhood
Child Health
Pediatrics
Perinatology
Cystic Fibrosis
Postgraduate Medical Journal
Medicine
